Providence Therapeutics
Biotechnology Research • 
Calgary, Alberta, Canada • 51-100 Employees
Company overview
| Headquarters | 120, 8832 Blackfoot Trail, Calgary, Alberta T2J 3J1, CA |
| Phone number | +14034403599 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biotech, Cancer Vaccines, Mrna Therapeutics, Lipid Nanoparticles, Covid-19 Vaccine, Personalized Vaccines |
| Founded | 2015 |
| Employees | 51-100 |
| Socials |
Key Contacts at Providence Therapeutics
Jordan Schwartz
Director Of Partnerships And Innovation
Líliam Oliveira Phd
Director
Leighette Ohryn
Senior Director, People & Culture
Mélanie Bérubé
Senior Director Preclinical/Nonclinical Studies
Providence Therapeutics Email Formats
Providence Therapeutics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@providencetherapeutics.com), used 78% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@providencetherapeutics.com | 78% |
{first initial} | j@providencetherapeutics.com | 12.2% |
{first initial}.{last name} | j.doe@providencetherapeutics.com | 9.8% |
About Providence Therapeutics
Providence Therapeutics Holdings Inc is a clinical-stage biotechnology company focused on drug development and platform development. The Providence mRNA Medicines platform is comprised of three integrated platforms: 1) mRNA Medicines Platform, 2) INTENT™ Lipid Nanoparticle Platform (LNP), and 3) Manufacturing Platform. Providence’s mRNA and INTENT™ LNP platform offer an end-to-end solution for designing codon-optimized ultrapure mRNA that can be formulated in application optimized LNP. The Providence proprietary INTENT™ LNP platform, consists of rationally designed lipids that have been tested for suitability for programs in oncology, infectious diseases and gene delivery. Our scalable, efficient platform demonstrates differentiated capabilities in mRNA design, manufacturing, and formulation processes, as well as specific organ and tissue targeting. For more information, please visit providencetherapeutics.com
Providence Therapeutics revenue & valuation
| Annual revenue | $5,133,300 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $16,500,000 |
| Total funding | $2,100,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Providence Therapeutics has 26 employees across 8 departments.
Departments
Number of employees
Providence Therapeutics Tech Stack
Discover the technologies and tools that power Providence Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
CDN
UI frameworks
JavaScript libraries
Tag managers
JavaScript libraries
CDN
Miscellaneous
Video players
UI frameworks
Analytics
UI frameworks
Belgium
United Kingdom
Denmark
Ireland
Australia
United States
Switzerland
Frequently asked questions
4.8
40,000 users
